Genetic architecture
The lane
- Status
- Enabler. Tools, methods and resources that the other lanes depend on.
- Verdict
- Risk genes feed every other branch; most are tagged in the branch they opened.
- Family
- Genetics
- Landmarks
- 25 in this lane, 24 more tagged with it. Advanced 7 · Open 14 · Dead end 4
The verdict and status come from the project's branches.yaml and use research wording.
Landmarks in this lane
| UCHL1 I93M (PARK5) | 1998 | Discovery | Did not hold up | – | – | 19 Oct 2026 | 3 |
| Twin study: genes matter little after age 50 | 1999 | Discovery | Confirmed and built on | – | – | 19 Oct 2026 | 2 |
| MAPT (tau) H1 haplotype | 2000–2009 | Discovery | Still being studied | – | – | 19 Oct 2026 | 3 |
| POLG mutations cause parkinsonism | 2004 | Discovery | Still being studied | – | – | 19 Oct 2026 | 3 |
| HTRA2/Omi (PARK13) did not hold up | 2005–2021 | Discovery | Did not hold up | – | – | 20 Oct 2026 | 4 |
| FBXO7 (PARK15) and PLA2G6 (PARK14) | 2008–2013 | Discovery | Confirmed and built on | – | – | 19 Oct 2026 | 4 |
| GIGYF2 and EIF4G1: disputed genes | 2008–2015 | Discovery | Did not hold up | – | – | 19 Oct 2026 | 2 |
| First GWAS: SNCA, MAPT, then 24 loci | 2009–2014 | Discovery | Confirmed and built on | – | – | 19 Oct 2026 | 2 |
| DCTN1 mutations cause Perry syndrome | 2009 | Discovery | Confirmed and built on | – | – | 19 Oct 2026 | 3 |
| DNAJC6 and SYNJ1: juvenile parkinsonism | 2012–2013 | Discovery | Still being studied | – | – | 19 Oct 2026 | 3 |
| RAB39B: X-linked parkinsonism | 2014–2015 | Discovery | Still being studied | – | – | 19 Oct 2026 | 3 |
| GCH1 variants raise risk | 2014 | Discovery | Still being studied | – | – | 19 Oct 2026 | 4 |
| DNAJC13 and TMEM230: disputed genes | 2014–2021 | Discovery | Did not hold up | – | – | 20 Oct 2026 | 6 |
| Polygenic risk scores and their limits | 2015–2019 | Discovery | Still being studied | – | – | 20 Oct 2026 | 4 |
| VPS13C recessive parkinsonism | 2016 | Discovery | Still being studied | – | – | 20 Oct 2026 | 2 |
| One faulty copy of PINK1: risk not confirmed | 2017–2022 | Discovery | Still being studied | – | – | 19 Oct 2026 | 3 |
| LRP10 | 2018–2021 | Discovery | Still being studied | – | – | 20 Oct 2026 | 4 |
| 90 genetic risk signals | 2019 | Discovery | Confirmed and built on | – | – | 20 Oct 2026 | 1 |
| Age-at-onset and progression GWAS | 2019–2023 | Discovery | Still being studied | – | – | 20 Oct 2026 | 4 |
| LARGE-PD Latino GWAS | 2020–2021 | Discovery | Confirmed and built on | – | – | 20 Oct 2026 | 4 |
| One faulty copy of PRKN is probably not a risk factor | 2020–2022 | Discovery | Still being studied | – | – | 20 Oct 2026 | 3 |
| ATP10B loss-of-function raises risk | 2020–2025 | Discovery | Still being studied | – | – | 20 Oct 2026 | 3 |
| PSAP (prosaposin) variants | 2020–2021 | Discovery | Still being studied | – | – | 20 Oct 2026 | 3 |
| African and multi-ancestry GWAS | 2023–2024 | Discovery | Confirmed and built on | – | – | 20 Oct 2026 | 2 |
| LRP10 and alpha-synuclein secretion | 2024 | Discovery | Still being studied | – | – | 20 Oct 2026 | 3 |
Also tagged with this lane
| First Parkinson's gene: SNCA | 1997 | Discovery | Confirmed and built on | – | – | 19 Oct 2026 | 4 |
| Parkin mutations cause juvenile parkinsonism | 1998 | Discovery | Confirmed and built on | – | – | 19 Oct 2026 | 2 |
| Further SNCA point mutations | 1998–2013 | Discovery | Confirmed and built on | – | – | 19 Oct 2026 | 5 |
| Extra copies of the synuclein gene cause Parkinson's | 2003 | Discovery | Confirmed and built on | – | – | 19 Oct 2026 | 5 |
| DJ-1 mutations cause early-onset parkinsonism | 2003 | Discovery | Still being studied | – | – | 19 Oct 2026 | 3 |
| The LRRK2 gene: the first gene-based drug target | 2004 | Discovery | Still being studied | – | – | 19 Oct 2026 | 0 |
| PINK1 and the mitophagy pathway | 2004 | Discovery | Still being studied | – | – | 19 Oct 2026 | 4 |
| SNCA duplications: ordinary-looking Parkinson's, partial penetrance | 2004–2009 | Discovery | Confirmed and built on | – | – | 19 Oct 2026 | 5 |
| ATP13A2 and Kufor-Rakeb syndrome | 2006 | Discovery | Still being studied | – | – | 19 Oct 2026 | 3 |
| SNCA Rep1 promoter variant raises risk | 2006 | Discovery | Confirmed and built on | – | – | 19 Oct 2026 | 2 |
| GBA mutations: commonest genetic risk factor | 2009 | Discovery | Confirmed and built on | – | – | 19 Oct 2026 | 3 |
| HLA-DR region GWAS signal | 2010 | Discovery | Still being studied | – | – | 19 Oct 2026 | 3 |
| VPS35 mutation and the retromer | 2011 | Discovery | Still being studied | – | – | 19 Oct 2026 | 3 |
| Patient-derived dopamine neurons | 2011 | Research model | Confirmed and built on | – | – | 19 Oct 2026 | 3 |
| TMEM175: a lysosome channel | 2014–2026 | Discovery | Still being studied | – | – | 19 Oct 2026 | 4 |
| CHCHD2 (PARK22) | 2015 | Discovery | Still being studied | – | – | 20 Oct 2026 | 4 |
| A risk variant that regulates SNCA | 2016 | Discovery | Still being studied | – | – | 20 Oct 2026 | 2 |
| Lysosomal storage disease genes as a group raise risk | 2017 | Discovery | Confirmed and built on | – | – | 20 Oct 2026 | 3 |
| AMP PD data platform | 2018–2021 | Research infrastructure | Confirmed and built on | – | – | 20 Oct 2026 | 2 |
| ASAP and GP2 | 2019–2021 | Research infrastructure | Still being studied | – | – | 20 Oct 2026 | 6 |
| 23andMe and UK Biobank cohorts | 2019–2020 | Research infrastructure | Confirmed and built on | – | – | 20 Oct 2026 | 3 |
| PD GENEration: free genetic testing | 2019–2024 | Research infrastructure | Still being studied | – | – | 20 Oct 2026 | 3 |
| FOUNDIN-PD dopamine-neuron atlas | 2021–2023 | Research infrastructure | Confirmed and built on | – | – | 19 Oct 2026 | 5 |
| RAB32 Ser71Arg | 2024 | Discovery | Confirmed and built on | – | – | 20 Oct 2026 | 2 |
Links with other lanes
Built on work from
- Mitochondria & energy: 9 links
- Synuclein misfolding & spread: 8 links
- Lysosome & GBA: 4 links
- LRRK2: 2 links
- Infrastructure & funding: 1 link
- Environment & lifestyle: 1 link
Led to work in
- Infrastructure & funding: 2 links
- Environment & lifestyle: 1 link
- Models: 1 link
- Selective vulnerability: 1 link